Microfluidic Droplet Interface Bilayer Networks for Drug Permeability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for predicting oral drug absorption, such as cell-based assays and artificial membrane models, face limitations including biological dissimilarity, high time and labor requirements, and lack of control over assay composition, particularly in mimicking true phospholipid bilayers found in cells.
Innovation Solution
Microfluidic devices create pharmacokinetic compartment models using droplet interface bilayer (DIB) networks with human-mimetic phospholipid compositions, allowing for the prediction of drug absorption by forming tripartite DIB networks that mimic the intestinal space, enterocyte, and blood compartments, enabling the measurement of drug diffusion rates and permeability coefficients.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cell-based assays are used to predict drug absorption, then the ability to model both passive diffusion and carrier-mediated transport is improved, but the time and labor requirements increase
Solution Approach 1:
The invention creates artificial membrane models that copy the essential functional properties of cell membranes without using living cells. The supported lipid bilayers replicate the phospholipid bilayer structure and transport properties, allowing measurement of apparent permeability coefficients without the complexity of cell-based systems.
Solution Approach 2:
The invention extracts the essential membrane transport function from complex cell systems by using artificial lipid bilayers that specifically model passive diffusion and carrier-mediated transport without including other cellular functions. This isolates the transport mechanism for efficient measurement.
2Ease of operation
If artificial membrane models like PAMPA are used, then labor requirements are reduced and lipoidal diffusion can be isolated, but the ability to resemble true phospholipid bilayers is insufficient
Solution Approach 1:
The invention changes the physical and chemical parameters of artificial membranes by using supported lipid bilayers with specific phospholipid compositions that closely match natural cell membranes. The bilayers are formed on porous supports with controlled pore sizes and surface properties, creating membranes with realistic thickness, fluidity, and transport properties.
Solution Approach 2:
The invention uses composite structures combining porous support materials with phospholipid bilayers. The support provides mechanical stability while the lipid bilayer provides the functional membrane properties, creating an artificial membrane that combines ease of handling with biological realism.
3Reliability
If supported lipid bilayers are used to model enterocytes, then the resemblance to true cell membranes is improved, but the complexity of the assay system increases
Solution Approach 1:
The invention segments the complex enterocyte into simplified functional compartments using separate artificial membranes for apical and basolateral surfaces. Each membrane can be independently prepared and characterized, reducing overall system complexity while maintaining physiological relevance through controlled assembly.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microfluidic devices provide a high-throughput, reproducible method for predicting pharmacologically relevant drug absorption with greater similarity to true biological systems than existing methods, allowing for rapid formation of multiple assays and accurate calculation of permeability coefficients, thus improving drug development processes.
Implementation Method 1
Each pair of adjacent droplets can comprise a phospholipid bilayer between them
Implementation Method 2
measuring a rate of movement of the pharmaceutical agent, and determining a diffusion model for the pharmaceutical agent
Data Source
AI summary
A microfluidic device can include a plurality of channels defined in a substrate and a plurality of rails defined in a substrate. Each channel can comprise a respective channel inlet, a respective channel outlet, and one or more respective non-miscible fluid inlets fluidly coupled to the channel inlet. Each rail can comprise a rail inlet, and each channel outlet can be coupled to a respective rail inlet. One or more fluids introduced via the channel inlets can form first, second, and third droplets, respectively, and the plurality of rails can comprise first, second, and third rails configured such that droplets disposed on the rails form a tripartite droplet interface bilayer (DIB) network.